Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ruboxistaurin is a PKC beta inhibitor. Ruboxistaurin reduces oxidative stress and attenuates left ventricular hypertrophy and dysfunction in rats with streptozotocin-induced diabetes. Ruboxistaurin attenuates diabetic nephropathy via modulation of TGF-β1/Smad and GRAP pathways. Ruboxistaurin inhibits retinal neovascularization via suppression of phosphorylation of ERK1/2 and Akt.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
25 mg | 約10-14 週間 | ¥ 153,500 |
50 mg | 約10-14 週間 | ¥ 199,500 |
100 mg | 約10-14 週間 | ¥ 301,000 |
説明 | Ruboxistaurin is a PKC beta inhibitor. Ruboxistaurin reduces oxidative stress and attenuates left ventricular hypertrophy and dysfunction in rats with streptozotocin-induced diabetes. Ruboxistaurin attenuates diabetic nephropathy via modulation of TGF-β1/Smad and GRAP pathways. Ruboxistaurin inhibits retinal neovascularization via suppression of phosphorylation of ERK1/2 and Akt. |
別名 | LY-333531, LY333531, LY 333531, LY-333531 Mesylate |
分子量 | 564.65 |
分子式 | C29H32N4O6S |
CAS No. | 192050-59-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Ruboxistaurin mesylate 192050-59-2 LY333531 Mesylate LY-333531 LY333531 LY 333531 LY 333531 Mesylate Ruboxistaurin Mesylate LY-333531 Mesylate Inhibitor inhibitor inhibit